US Patent 8026395 Process for the synthesis of anti-neoplasia agent VNP40101M
Patent 8026395 was granted and assigned to Nanotherapeutics, Inc. on September, 2011 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8026395 Process for the synthesis of anti-neoplasia agent VNP40101M
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.